Alveolus Bio

Birmingham, United States

Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.

$2.0M raised

Jul 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Alveolus Bio raised?

Alveolus Bio has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in July 2025.

Who are Alveolus Bio's investors?

Alveolus Bio's investors include Shilpa Medicare, Innovate Alabama, National Heart, Lung and Blood Institute.

Where is Alveolus Bio headquartered?

Alveolus Bio is headquartered in Birmingham, United States.

What does Alveolus Bio do?

Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.

What stage is Alveolus Bio at?

Alveolus Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 25, 2025.

MLA

"Alveolus Bio — Funding & Investors." VCBacked, July 25, 2025, https://www.vcbacked.co/company/alveolus-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Alveolus Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/alveolus-bio

Wikipedia (cite web)

{{cite web |title=Alveolus Bio — Funding & Investors |url=https://www.vcbacked.co/company/alveolus-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 25, 2025.